VSWA
AGN

Vontobel Swiss Wealth Advisors’s Allergan plc AGN Stock Holding History

Vontobel Swiss Wealth Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,400
Closed -$602K – 90
2020
Q1 		$602K Hold
3,400
– – 0.46% 48
2019
Q4 		$650K Hold
3,400
– – 0.43% 58
2019
Q3 		$572K Hold
3,400
– – 0.37% 62
2019
Q2 		$569K Buy
+3,400
New +$471K 0.31% 70

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Vontobel Swiss Wealth Advisors's AGN Position: Q2 2020 in Review

Vontobel Swiss Wealth Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,400 shares — an estimated $602K sold.

Vontobel Swiss Wealth Advisors first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $650K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Vontobel Swiss Wealth Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Vontobel Swiss Wealth Advisors sold 3,400 Allergan plc shares in Q2 2020, an estimated $602K.
  • Vontobel Swiss Wealth Advisors first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Vontobel Swiss Wealth Advisors's Allergan plc position peaked at $650K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q2 2020, filed 31 Jul 2020.